By combining TF-binding site (TFBS) information with epigenomics-based markers of cis-regulatory segments and differential expression of nearby genes, we were able to identify the TFs most likely to regulate CRC progression, as well as their putative target genes. This evidence concerns the gene TF and colorectal carcinoma.